Our follow-up study showed that tumor-infiltrating (TI)-Treg cells have elevated expression of BCL-XL, at much higher levels than Treg cells from paired blood or effector T cells from tumors or blood [45]. This evidence concerns the gene BCL2L1 and neoplasm.